Background/aim: Sinonasal polyposis is a complex chronic disease displaying contributions of multiple genetic and environmental factors. In this study, we analyzed possible genetic factors that increase susceptibility to this widespread inflammatory disease. 
1.Introduction:
Despite the fact that nasal polyposis was described for the first time by Hippocrates, its pathogenesis still remains to be clarified. Nasal polyposis is generally regarded to involve a multitude of genetic and environmental factors; however, the exact mechanism that starts the ongoing inflammation is still debated. In the 2012 European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) documents, nasal polyposis was defined as a subgroup of chronic sinusitis (CRSwNP) [1] . Altered expression levels of cytokines and chemokines with proinflammatory, anti-inflammatory or angiogenic features are one of the hypotheses considering the etiopathogenesis of sinonasal polyposis.
A number of pro-and anti-inflammatory cytokines are believed to play a role in the inflammatory response of sinonasal polyposis. Genetic polymorphisms have been considered to be important regarding the definition of the susceptibility profile for the development of this disease. The IL-1 family is a group of epithelial cytokines combining potent pro-inflammatory cytokines, IL-1α and IL-1β, and their negative regulator with an anti-inflammatory effect is the IL-1 receptor antagonist (IL-1RN) [2] .
The genes encoding the IL-1 family are located on the long arm of chromosome 2. The IL-1RN gene has a penta-allelic polymorphic site in the intron 2 region due to the presence of an 86-bp variable number of a tandem repeat (VNTR) sequence [3, 4] .
VNTR may result in genetic variations in an individual and may further alter the rate of gene transcription, the stability of mRNA, or the quantity and activity of the encoded protein. Individuals with different copy numbers of the repeat sequences differ in the number of potential protein binding sites, thereby altering the amounts of cytokine production [5] . IL-1RN gene polymorphisms have been associated with the severity of or susceptibility to various inflammatory disorders [6] .
IL-2 is a lymphokine produced by T cells and plays a major role in T and B cell cooperation. It induces the secretion of IL-1, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α and TNF-β. IL-2 has powerful immunoregulatory effects on a variety of immune cells [7] . The gene coding for IL-2 is located on chromosome 4q26-q27 [8] .
There is a functional T→G single nucleotide polymorphism (SNP) at position -330 and it is suggested that this polymorphism can be useful as a marker to diagnose the susceptibility to various inflammatory diseases [9] .
IL-4 is a prototypic member of Th2 cytokines and has potent anti-inflammatory features. It reduces the production and impact of proinflammatory cytokines and is also involved in the isotype switching from immunoglobulin (Ig)M/IgG to IgE by B lymphocytes [10, 11] . The IL-4 gene is located on chromosome 5q31-q33. The IL-4 variable number of tandem repeat (VNTR) polymorphism is characterized by a rare Rp1 allele (2 repeats = 183 bp), a frequent Rp2 allele (3 repeats = 253 bp), and Rp3 (4 repeats), which is a rarer allele.
In the present study, the association of IL-1RN VNTR, IL-2(-330), and IL-4 VNTR polymorphisms with sinonasal polyposis was evaluated.
Materials and methods

Subjects:
In this current study, we included 78 patients with nasal polyposis and 98 healthy controls with no history of nasal symptoms. The diagnosis of nasal polyposis was made either by anterior rhinoscopy through various nasal endoscopes (The endoscopic equipment consists of a series of various rigid rod lens Hopkins telescopes, a digital one-chip camera a Xenon cold light source, a high-resolution video monitor screen . All equipment was provided by Karl Storz Company, Tuttlingen, Germany) and computed tomography scans were performed to prevent any misdiagnoses. Patients with Samter's triad or asthma were not included in this study. Our research was approved by the ethics committee of Adana City Education and Research Hospital. All patients and control subjects were informed about the study and their written informed consents were obtained before commencing the study. Blood samples were collected in EDTAcoated vials, and stored at -20°C until required for genomic DNA extraction.
DNA extraction, oligonucleotide primers, PCR amplification, and restriction digestion:
Genomic DNA was isolated from 250 μL of whole blood from each sample using proteinase K followed by an E.Z.N.A.® Tissue Kit II in accordance with the manufacturer's protocol. All DNA samples were examined at 260/280 nm absorbance ratio using a PeQLab Nanodrop (Biotechnologie GmbH). PCR amplifications were performed using three primer pairs (Table 1) .
Briefly, PCR was performed in a final volume of 25 μL, containing 50 ng genomic DNA template, 10X PCR buffer with 50 Mm MgCl 2 , 100-500 nM of each primer, 10 μM dNTPs, and 5 U DNA polymerase. The DNA was initially denatured at 94°C for 5 min prior to amplification. PCR amplification was accomplished using 35 cycles, consisting of 30 seconds denaturation at 94°C, 45 seconds of annealing at 50°C for IL-1RN, at 58°C for IL-4, at 52°C for IL2-330 primers, and 30 seconds of extension at 72°C, and the final extension cycle at 72°C for 5 min. The PCR fragments of IL-1RA and IL-4 were separated using 1.5% agarose gel electrophoresis.
IL-2 -330 (rs2069762) SNP genotyping was performed using PCR-restriction fragment length polymorphism (PCR-RFLP). Restriction digestion was performed with PCR products of IL2-330 in a total volume of 10 μL amplicons, 2 μL 10X buffer "Tango" and 10 units of FspBI (Bfal) enzyme. The samples were then incubated for 16 h at 37°C and the digested PCR products were separated using 3% agarose gel electrophoresis stained with ethidium bromide and visualized on a UV transilluminator with 50 base pair DNA ladder and photographed. After FspBI digestion, the IL2-330 products were separated into three fragments (A1,150bp; A1/A2, 150,127; and 23bp; A2, 127 and 23bp).
Statistics:
The Statistical Package for the Social Sciences (SSPS) version 20 for Windows was applied for the statistical analysis of this study. The allel frequencies between the groups was analyzed by using the Chi square test and Fisher's exact test.
Results
This present study included a total of 176 subjects, 78 patients with nasal polyposis and 98 healthy controls. The age of the nasal polyposis patients ranged from 15 to 80 years (mean: 49 years). 72% of the patient group was male and 28% was female. The age range of the control group was between 19 and 78 years (mean: 44 years). In the control group, 65% were male and 35% were female. This study genotyped the patient and the control group for the three polymorphisms. The IL-2(-330) allelic distribution showed a preponderance of the homozygous dominant A1 alleles. The A1 allele occurred approximately three times more frequently in the study population than the A2 or mutant allele. Genotyping showed that the homozygous dominant genotype (A1A1) was also the most frequent in the study population, occurring at a frequency of 33.3%. The frequency of the heterozygote genotype (A1A2) was 55%, and the mutant alleles (A2A2) were the least frequent, occurring at a frequency of only 11.66%. Distribution of genotypes frequencies of IL-1RA, IL-2 (-330) and IL-4 gene polymorphisms are shown in Table 2 .
Discussion:
The present research is the first study to evaluate the role of IL-1RN, IL-2, and IL-4 gene polymorphisms in a Turkish population with nasal polyposis. Growing evidence implicates the contribution of genetic and environmental factors to the pathogenesis of chronic inflammatory diseases such as sinonasal polyposis. Our study has shown significantly higher incidence of RN2 and RP1 alleles in patients. IL-1 and IL-4 seem to play an important role in the pathogenesis of nasal polyposis because they activate and mobilize eosinophils, and stimulate the differentiation and growth of B lymphocytes [12] .
The IL-1 receptor antagonist gene polymorphism has been linked with a huge variety of diseases in the literature. Its association with preeclampsia, psoriasis, asthma, sepsis, inflammatory bowel disease, systemic lupus erythematosus, gastritis, schizophrenia, intellectual disability, cervical cancer, and even tonsillar hypertrophy has been studied recently [13] [14] [15] [16] [17] [18] [19] .
The correlation between the IL-1 RN gene polymorphism and asthma has been demonstrated by various studies from Turkey, Egypt, South Africa, North India, and Japan [20] [21] [22] [23] . However, only one study has analyzed its relationship with chronic rhinosinusitis [24] . In the study of Cheng et al.,
where the study population included adult Taiwan Behçet's disease in Turkish population have all been studied previously [43] [44] [45] [46] [47] [48] [49] . IL-4 VNTR gene polymorphisms are also linked with immune thrombocytopenic purpura (ITP) and asthma in the current literature [50, 51] . Also, IL-4 and IL-1RN (VNTR) gene polymorphisms are together linked to frailty syndrome, and type 2 diabetes mellitus [52, 53] . In our research, we found that IL-4 VNTR polymorphisms were significantly associated with nasal polyps in the Turkish population (p = 0.036). Our study shows the effect of the RP1 allele of IL-4 on the susceptibility of polyposis formation in patients with CRSwNP.
In conclusion, the etiopathogenesis of sinonasal polyposis is still an unsolved puzzle of the otorhinolaryngologic society. The theories that try to enlighten the exact mechanism for the chronic inflammation become more complex every day. In this study, we researched the possible gene polymorphism associations and found that the 
